Place it in its market
Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.
See how Context works →On the price, the facts of the public record■Insider buy□Insider sell●Results filed
With an account, also○dividends▲splits◌next earningswith an account
End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.
Latest on record
The most recent facts, as filed.
Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.
- Oct 13, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
- Sep 18, 2026Reported sale · Form 4Kumar Budur, CHIEF MEDICAL OFFICER · $1.5MOpen the filing ↗
- Sep 18, 2026Notice of sale · Form 144KUMAR BUDUR · Officer · $1.5MOpen the filing ↗
In numbers
What this profile holds, counted.
Closes · 1 year250
SEC filings on record43913 flagged findings
Reported transactions (Form 4)80since Sep 30, 2025 · and 8 other holdings
Corporate events (8-K)29since Sep 1, 2020
What the record says
Description, identity and filings, each with its source.
Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.
Regulatory history
Topics detected in its SEC reports, with the original excerpt.
Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.
- 2026-08-04capital return (buybacks/dividends)freshOpen filing ↗“…any dividends declared by the Company’s board of directors out of funds legally available for that purpose, subject to any…”
+1 more passage from the same document
- “…available for that purpose, subject to any preferential dividend rights of any outstanding preferred stock. The Company’s common…”
- 2026-08-04merger or acquisition eventfreshOpen filing ↗“…previously granted, and (iii) up to 1,005 shares of the Company’s common stock related the Company’s employee stock purchase plan,…”
Original excerpts from SEC filings, untranslated. Not advice and not a prediction.
The 25 most recent filings (of 439)
Every SEC filing, newest first, with what it is. Below, each type with its own explanation.
- Oct 13, 268-K ↗Current report · A senior executive left or was appointed new
- Sep 18, 26Form 4 ↗Insider transaction
Notice of proposed sale · 3 Form 144 filingsshow all 3hide
- Sep 18, 26Form 144 ↗Notice of proposed sale
- Sep 17, 26Form 144 ↗Notice of proposed sale
- Sep 16, 26Form 144 ↗Notice of proposed sale
- Sep 9, 26Form 4 ↗Insider transaction
Notice of proposed sale · 3 Form 144 filingsshow all 3hide
- Sep 8, 26Form 144 ↗Notice of proposed sale
- Sep 4, 26Form 144 ↗Notice of proposed sale
- Aug 7, 26Form 144 ↗Notice of proposed sale
- Aug 4, 2610-Q ↗Quarterly report
- Aug 4, 268-K ↗Current report · Results · Communication to the market
- Jul 31, 26SCHEDULE 13G ↗Passive stake · Vanguard Portfolio Management · 5.1% · event on Jun 30, 26
- Jul 28, 26SCHEDULE 13G/A ↗Passive stake · BlackRock, Inc. · 11.3% · event on Jun 30, 26 · amendment
- Jul 22, 26Form 3 ↗Insider transaction
- Jul 16, 268-K ↗Current report · A senior executive left or was appointed
Notice of proposed sale · 7 Form 144 filingsshow all 7hide
- Jul 2, 26Form 144 ↗Notice of proposed sale
- Jun 30, 26Form 144 ↗Notice of proposed sale
- Jun 26, 26Form 144 ↗Notice of proposed sale
- Jun 24, 26Form 144 ↗Notice of proposed sale
- Jun 9, 26Form 144 ↗Notice of proposed sale
- Jun 5, 26Form 144 ↗Notice of proposed sale
- Jun 4, 26Form 144 ↗Notice of proposed sale
439 filings on record, the oldest from Mar 12, 20.
Listing the 25 most recent filings of the 439 on record.
920
8 senior executive changes2024 – 2026show all 8hide
- Oct 13, 26A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Jul 16, 26A senior executive left or was appointed+3 more in the same filing8-K 5.02 ↗
- Apr 14, 26A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Apr 2, 26A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Apr 3, 25A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Mar 24, 25A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Jul 1, 24A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- May 3, 24A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Apr 11, 24Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Nov 8, 23A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Oct 11, 23Completed an acquisition or disposal+2 more in the same filing8-K 2.01 ↗
- Oct 5, 23A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
4 material agreements entered2023show all 4hide
- Sep 25, 23Entered a material agreement+1 more in the same filing8-K 1.01 ↗
- Sep 14, 23Entered a material agreement+1 more in the same filing8-K/A 1.01 ↗
- Aug 14, 23Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Jul 27, 23Entered a material agreement+3 more in the same filing8-K 1.01 ↗
10 senior executive changes2020 – 2023show all 10hide
- May 31, 23A senior executive left or was appointed8-K/A 5.02 ↗
- Apr 24, 23A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Jan 23, 23A senior executive left or was appointed+1 more in the same filing8-K/A 5.02 ↗
- Jan 23, 23A senior executive left or was appointed8-K 5.02 ↗
- Jan 6, 23A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Nov 22, 21A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Jun 15, 21A senior executive left or was appointed8-K 5.02 ↗
- Mar 15, 21A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Mar 10, 21A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Nov 12, 20A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Oct 14, 20Took on a new financial obligation+2 more in the same filing8-K 2.03 ↗
- Sep 1, 20Sold unregistered shares+1 more in the same filing8-K 3.02 ↗
Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.
Schedule 13G: short-form filing
The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.
- BlackRock, Inc.11.3%Jun 30, 26SCHEDULE 13G/A ↗2 earlier filings
- Marshman Fund Trust II10.6%Dec 31, 24SCHEDULE 13G/A ↗
- The Vanguard Group8.3%Dec 31, 24SCHEDULE 13G/A ↗
- FMR LLC5.4%Dec 31, 25SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
- Vanguard Portfolio Management5.1%Jun 30, 26SCHEDULE 13G ↗
show one more holderhide
- Antonio J. Gracias3.2%Sep 30, 25SCHEDULE 13G/A ↗9 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.
Sale intention announced
On Sep 18, KUMAR BUDUR filed notice of intent to sell up to $1.5M. That is about 0.06% of shares outstanding. It is filed under a scheduled plan (10b5-1), arranged in advance.
A notice is not a sale: it may not go ahead, may happen in part, or at a different price.
After the notice, they sold $1.5M on Sep 18, per their Form 4. That is 100% of the shares announced so far, and the window is still open.
View notice (Form 144) ↗+9 more recent notices · 4 with a later sale
- Sep 18, 26Sell$1.5MKumar BudurCHIEF MEDICAL OFFICER↗
- Sep 17, 26Sell$34KKumar BudurCHIEF MEDICAL OFFICER↗
- Sep 16, 26Sell$77KKumar BudurCHIEF MEDICAL OFFICER↗
- Sep 8, 26Sell$190KKumar BudurCHIEF MEDICAL OFFICER↗
- Sep 8, 26Sell$43KKumar BudurCHIEF MEDICAL OFFICER↗
- Sep 8, 26Sell$989KKumar BudurCHIEF MEDICAL OFFICER↗
- Sep 4, 26Sell$231KKumar BudurCHIEF MEDICAL OFFICER↗
- Jan 26, 26Sell$139KSandip KapadiaCHIEF FINANCIAL OFFICER↗
- Jan 15, 26Sell$753KSandip KapadiaCHIEF FINANCIAL OFFICER↗
- Dec 12, 25Sell$802KJeffrey M. DaynoPRESIDENT, CEO↗
- Dec 12, 25Sell$238KJeffrey M. DaynoPRESIDENT, CEO↗
Stock compensation, tax and giftsshow the 29 other transactionshide
Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.
- Sep 18, 26Compensation$319KKumar BudurCHIEF MEDICAL OFFICER↗
- Sep 18, 26Compensation$770KKumar BudurCHIEF MEDICAL OFFICER↗
- Sep 17, 26Compensation$12KKumar BudurCHIEF MEDICAL OFFICER↗
- Sep 17, 26Compensation$12KKumar BudurCHIEF MEDICAL OFFICER↗
- Sep 16, 26Compensation$28KKumar BudurCHIEF MEDICAL OFFICER↗
- Sep 16, 26Compensation$27KKumar BudurCHIEF MEDICAL OFFICER↗
- Sep 8, 26Compensation$374KKumar BudurCHIEF MEDICAL OFFICER↗
- Sep 8, 26Compensation$326KKumar BudurCHIEF MEDICAL OFFICER↗
- May 1, 26Compensationamount n/aKumar BudurCHIEF MEDICAL OFFICER↗
- May 1, 26Tax$283KKumar BudurCHIEF MEDICAL OFFICER↗
- Apr 7, 26Compensationamount n/aAdam H. ZaeskeCHIEF COMMERCIAL OFFICER↗
- Apr 7, 26Tax$88KAdam H. ZaeskeCHIEF COMMERCIAL OFFICER↗
- Jan 25, 26Compensationamount n/aJeffrey M. DaynoPRESIDENT, CEO↗
- Jan 25, 26Tax$208KJeffrey M. DaynoPRESIDENT, CEO↗
- Jan 25, 26Compensationamount n/aSandip KapadiaCHIEF FINANCIAL OFFICER↗
- Jan 25, 26Tax$94KSandip KapadiaCHIEF FINANCIAL OFFICER↗
- Jan 25, 26Compensationamount n/aAndrew SerafinCHIEF STRATEGY OFFICER↗
- Jan 25, 26Tax$41KAndrew SerafinCHIEF STRATEGY OFFICER↗
- Jan 25, 26Compensationamount n/aKumar BudurCHIEF MEDICAL OFFICER↗
- Jan 25, 26Tax$51KKumar BudurCHIEF MEDICAL OFFICER↗
- Jan 24, 26Compensationamount n/aJeffrey M. DaynoPRESIDENT, CEO↗
- Jan 24, 26Tax$176KJeffrey M. DaynoPRESIDENT, CEO↗
- Jan 24, 26Compensationamount n/aSandip KapadiaCHIEF FINANCIAL OFFICER↗
- Jan 24, 26Tax$82KSandip KapadiaCHIEF FINANCIAL OFFICER↗
- Jan 24, 26Compensationamount n/aAndrew SerafinCHIEF STRATEGY OFFICER↗
- Jan 24, 26Tax$41KAndrew SerafinCHIEF STRATEGY OFFICER↗
- Jan 24, 26Compensationamount n/aKumar BudurCHIEF MEDICAL OFFICER↗
- Jan 24, 26Tax$42KKumar BudurCHIEF MEDICAL OFFICER↗
- Dec 12, 25Compensation$164KJeffrey M. DaynoPRESIDENT, CEO↗
The full record holds 109 transactions and goes back to Mar 29, 23.
Its sector and its market
Harmony Biosciences Holdings, Inc. among Health Care companies
The profile shows what is on record. Context and Radar place the company among those of its sector and region.
Browse its neighbours
Other Health Care companies
With an account you also get
- The four engines — growth, trend, risk and context — each with its word and its score.
- The risk band and the sector phase.
- The company's fundamentals and accounts.
- Watchlist: your list of companies, with the «since you follow it» figure.
The research continues
The profile tells the story. The market sets the scene.
From Harmony Biosciences Holdings, Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.
See what deserves a closer look
Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.
See how Radar works →Keep the why
Follow Harmony Biosciences Holdings, Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.
See an example review →
Coverage
What sits behind this page.
Where each figure comes from and how far it reaches.
- Prices
- End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
- Series quality
- 250 clean closes in the period.
- SEC records
- 439 documents on file, from Mar 12, 2020 to Oct 13, 2026.
- Company description
- No description available.
- This page
- Generated on Oct 19, 2026; refreshed through the day.
Start at your own pace
Explore first. Go deeper with access.
Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.
Compare plans →- No account
This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.
- Pro
What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.
- Pro+
Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.
Are the prices real time?
No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.
Which SEC documents appear here?
Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.
Why does a European company show no SEC records?
It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.
Before forming a view on a company,
read what is on record.
One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.